Henry Schein, Inc. (HSIC) Stake Maintained by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC maintained its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,820 shares of the company’s stock at the end of the second quarter. Nisa Investment Advisors LLC’s holdings in Henry Schein were worth $4,545,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Bluestein R H & Co. increased its position in Henry Schein by 22.5% in the first quarter. Bluestein R H & Co. now owns 123,224 shares of the company’s stock valued at $20,944,000 after buying an additional 22,608 shares during the period. BlackRock Inc. increased its position in Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the period. Chevy Chase Trust Holdings Inc. increased its position in Henry Schein by 1.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 269,458 shares of the company’s stock valued at $45,800,000 after buying an additional 3,699 shares during the period. Azimuth Capital Management LLC increased its position in Henry Schein by 4.9% in the first quarter. Azimuth Capital Management LLC now owns 36,234 shares of the company’s stock valued at $6,159,000 after buying an additional 1,705 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Henry Schein by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 310,134 shares of the company’s stock valued at $52,714,000 after buying an additional 1,831 shares during the period. Institutional investors own 90.60% of the company’s stock.

Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded down 0.07% during midday trading on Friday, hitting $169.49. The company had a trading volume of 525,408 shares. The stock’s 50-day moving average price is $179.49 and its 200-day moving average price is $175.49. Henry Schein, Inc. has a one year low of $146.23 and a one year high of $186.99. The stock has a market capitalization of $13.40 billion, a price-to-earnings ratio of 24.77 and a beta of 1.09. Henry Schein shares are scheduled to split on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be distributed to shareholders after the closing bell on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.64 earnings per share. Analysts predict that Henry Schein, Inc. will post $7.27 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Henry Schein, Inc. (HSIC) Stake Maintained by Nisa Investment Advisors LLC” was reported by BNB Daily and is owned by of BNB Daily. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/19/nisa-investment-advisors-llc-continues-to-hold-stake-in-henry-schein-inc-hsic-updated-updated-updated.html.

Several equities analysts recently commented on HSIC shares. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Northcoast Research raised Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target for the company in a report on Monday, August 7th. BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Jefferies Group LLC reaffirmed a “hold” rating and set a $177.00 price target on shares of Henry Schein in a report on Friday, July 21st. Finally, Piper Jaffray Companies began coverage on Henry Schein in a report on Monday, June 12th. They set a “neutral” rating and a $200.00 price target for the company. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating to the company’s stock. Henry Schein presently has a consensus rating of “Hold” and an average price target of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply